Send mail to Author

Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___      _____     _____     ____       ___    
 /_____//   / _ \\   / ____||  |  ___||  |  _ \\    / _ \\  
 `____ `   / //\ \\ / //---`'  | ||__    | |_| ||  / //\ \\ 
 /___//   |  ___  ||\ \\___    | ||__    | .  //  |  ___  ||
 `__ `    |_||  |_|| \_____||  |_____||  |_|\_\\  |_||  |_||
 /_//     `-`   `-`   `----`   `-----`   `-` --`  `-`   `-` 
 `-`
 


Back to frontdoor view

OPUS4 Logo